Final Results of Local-Regional Control and Late Toxicity of RTOG 9003: A Randomized Trial of Altered Fractionation Radiation for Locally Advanced Head and Neck Cancer

At 5 years, only HFX improved LRC and overall survival for patients with locally advanced SCC without increasing late toxicity.